Business

Re-entering the Dragon: GSK returns to China after 12 years in blood cancer drug push

Daily Mail Money · 20 September 2026 at 06:01

Re-entering the Dragon: GSK returns to China after 12 years in blood cancer drug push

What a difference 12 years make.

In 2014 GlaxoSmithKline was fined £300m by a Chinese court for running a 'massive bribery network'.

Read the full article on Daily Mail Money ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.dailymail.co.uk — the content belongs to Daily Mail Money.

Re-entering the Dragon: GSK returns to China after 12 years in blood cancer drug push

More from Daily Mail Money

Ten things you didn't know about Jaguar's controversial new Type 01 EV

Scottish Mortgage has rocketed 38% this year, can it keep rising?

Stuart Machin of M&S is not sparing Labour's blushes, says ALEX BRUMMER

M&S boss tells Healey: Take the handcuffs off business and get Britain growing - as he savages Labour's 'crushing' tax policies just weeks ahead of first Burnham Budget

More in Business

Ten things you didn't know about Jaguar's controversial new Type 01 EV

Scottish Mortgage has rocketed 38% this year, can it keep rising?

Stuart Machin of M&S is not sparing Labour's blushes, says ALEX BRUMMER

M&S boss tells Healey: Take the handcuffs off business and get Britain growing - as he savages Labour's 'crushing' tax policies just weeks ahead of first Burnham Budget

The world of one trade — AI

Saudi flagship summits under pressure after deadly airport attacks